• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可切除结直肠转移的肝移植方案。

PROTOCOL FOR LIVER TRANSPLANTATION IN UNRESECTABLE COLORECTAL METASTASIS.

机构信息

Departamento de Gastroenterologia, Hospital de Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

Departamento de Cirurgia Geral e Transplantes, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brasil.

出版信息

Arq Bras Cir Dig. 2022 Jan 31;34(4):e1625. doi: 10.1590/0102-672020210002e1625. eCollection 2022.

DOI:10.1590/0102-672020210002e1625
PMID:35107487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8846472/
Abstract

AIM

Colorectal cancer (CRC) is the third most common neoplasm, and half of the patients with CRC develop liver metastasis. The best prognostic factor for colorectal liver metastasis (CRLM) is the possibility of performing a resection with free margins; however, most of them remain unresectable. The justification for performing liver transplantation (LT) in patients with CRLM regards an increase in the number of resectable patients by performing total hepatectomy. The aim of this study was to provide a Brazilian protocol for LT in patients with unresectable CRLM.

METHOD

The protocol was carried out by two Brazilian institutions, which perform a large volume of resections and LTs, based on the study carried out at the University of Oslo. The elaboration of the protocol was conducted in four stages.

RESULT

A protocol proposal for this disease is presented, which needs to be validated for clinical use.

CONCLUSION

The development of an LT protocol for unresectable CRLM aims to standardize the treatment and to enable a better evaluation of surgical results.

摘要

目的

结直肠癌(CRC)是第三大常见肿瘤,一半的 CRC 患者会发生肝转移。结直肠肝转移(CRLM)的最佳预后因素是能否进行无切缘限制的切除术;然而,大多数患者仍无法切除。在 CRLM 患者中进行肝移植(LT)的理由是通过实施全肝切除术增加可切除患者的数量。本研究的目的是为巴西不可切除 CRLM 患者的 LT 提供一个方案。

方法

该方案由两个巴西机构实施,这两个机构基于奥斯陆大学的研究进行了大量的切除术和 LT。方案的制定分为四个阶段进行。

结果

提出了一种针对该疾病的方案建议,需要进行临床验证。

结论

制定不可切除 CRLM 的 LT 方案旨在使治疗标准化,并能够更好地评估手术结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ea/8846472/5cc831814704/0102-6720-abcd-34-04-e1625-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ea/8846472/2ca1b0da8c34/0102-6720-abcd-34-04-e1625-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ea/8846472/5cc831814704/0102-6720-abcd-34-04-e1625-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ea/8846472/2ca1b0da8c34/0102-6720-abcd-34-04-e1625-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ea/8846472/5cc831814704/0102-6720-abcd-34-04-e1625-gf2.jpg

相似文献

1
PROTOCOL FOR LIVER TRANSPLANTATION IN UNRESECTABLE COLORECTAL METASTASIS.不可切除结直肠转移的肝移植方案。
Arq Bras Cir Dig. 2022 Jan 31;34(4):e1625. doi: 10.1590/0102-672020210002e1625. eCollection 2022.
2
PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA.肝门部胆管癌肝移植术的方案。
Arq Bras Cir Dig. 2022 Jan 5;34(3):e1618. doi: 10.1590/0102-672020210002e1618. eCollection 2022.
3
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.结直肠癌肝转移患者肝移植与肝切除的比较:根据肿瘤负荷评分分层的患者生存获益分析
Transpl Int. 2021 Sep;34(9):1722-1732. doi: 10.1111/tri.13981.
4
The role of liver transplantation for colorectal liver metastases: A systematic review and pooled analysis.肝移植治疗结直肠癌肝转移的作用:系统评价和荟萃分析。
Transplant Rev (Orlando). 2020 Oct;34(4):100570. doi: 10.1016/j.trre.2020.100570. Epub 2020 Aug 25.
5
Attitudes of Canadian Colorectal Cancer Care Providers towards Liver Transplantation for Colorectal Liver Metastases: A National Survey.加拿大结直肠癌治疗提供者对结直肠癌肝转移行肝移植的态度:一项全国性调查。
Curr Oncol. 2022 Jan 28;29(2):602-612. doi: 10.3390/curroncol29020054.
6
Liver Transplantation for Colorectal Liver Metastases.结直肠癌肝转移的肝移植
Surg Clin North Am. 2024 Feb;104(1):227-242. doi: 10.1016/j.suc.2023.08.003. Epub 2023 Sep 16.
7
A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.当代关于结直肠癌不可切除肝转移行肝移植的系统评价。
Cancer. 2022 Jun 15;128(12):2243-2257. doi: 10.1002/cncr.34170. Epub 2022 Mar 14.
8
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.KRAS、BRAF、PI3K和TP53基因突变分析对可切除和不可切除结直肠癌肝转移的临床意义及预后相关性:当前证据的系统评价
Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
9
[Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].[双侧多发性结直肠癌肝转移患者肝切除术后的长期结局——倾向评分匹配分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Oct 25;23(10):976-983. doi: 10.3760/cma.j.cn.441530-20200414-00204.
10
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).基于K-ras状态,采用含贝伐单抗或西妥昔单抗的mFOLFOX6方案将不可切除的结直肠癌肝转移转化为完全切除(BECK研究)。
J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):634-45. doi: 10.1002/jhbp.254. Epub 2015 Apr 29.

引用本文的文献

1
METACHRONOUS COLORECTAL LIVER METASTASIS.异时性结直肠癌肝转移
Arq Bras Cir Dig. 2025 Apr 7;38:e1874. doi: 10.1590/0102-6720202500005e1874. eCollection 2025.
2
SURGICAL TECHNIQUES TO INCREASE RESECTABILITY IN LIVER METASTASIS.提高肝转移瘤可切除性的手术技术
Arq Bras Cir Dig. 2025 Jan 20;37:e1859. doi: 10.1590/0102-6720202400065e1859. eCollection 2025.
3
COMPLICATIONS AFTER HEPATECTOMY.肝切除术后的并发症

本文引用的文献

1
RISK FACTORS ASSOCIATED WITH HEPATIC ARTERY THROMBOSIS: ANALYSIS OF 1050 LIVER TRANSPLANTS.与肝动脉血栓形成相关的危险因素:1050 例肝移植分析。
Arq Bras Cir Dig. 2021 Jan 25;33(4):e1556. doi: 10.1590/0102-672020200004e1556. eCollection 2021.
2
RISK FACTORS FOR POST-LIVER TRANSPLANT BILIARY COMPLICATIONS IN THE ABSENCE OF ARTERIAL COMPLICATIONS.无动脉并发症情况下肝移植术后胆道并发症的危险因素
Arq Bras Cir Dig. 2020 Dec 18;33(3):e1541. doi: 10.1590/0102-672020200003e1541. eCollection 2020.
3
Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patients.
Arq Bras Cir Dig. 2025 Jan 20;37:e1856. doi: 10.1590/0102-6720202400062e1856. eCollection 2025.
2020年结直肠癌肝转移可切除性的局限性——临床医生和患者的系统方法
Semin Cancer Biol. 2021 Jun;71:10-20. doi: 10.1016/j.semcancer.2020.09.008. Epub 2020 Sep 24.
4
Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence.肝移植治疗继发性肝脏肿瘤:生存与复发之间的艰难平衡。
J Hepatol. 2020 Dec;73(6):1557-1562. doi: 10.1016/j.jhep.2020.08.015. Epub 2020 Sep 5.
5
The ILTS Consensus Conference on Transplant Oncology: Setting the Stage.国际肝脏移植学会移植肿瘤学共识会议:拉开序幕。
Transplantation. 2020 Jun;104(6):1119-1120. doi: 10.1097/TP.0000000000003175.
6
Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference.肝移植治疗结直肠和神经内分泌肝脏转移瘤和肝母细胞瘤。ILTS 移植肿瘤学共识会议工作组报告。
Transplantation. 2020 Jun;104(6):1131-1135. doi: 10.1097/TP.0000000000003118.
7
LIVING DONOR LIVER TRANSPLANT FOR COLORECTAL LIVER METASTASIS: THE FIRST CASE IN LATIN AMERICA.活体供肝肝移植治疗结直肠癌肝转移:拉丁美洲首例病例。
Arq Bras Cir Dig. 2019 Dec 20;32(4):e1468. doi: 10.1590/0102-672020180001e1468. eCollection 2019.
8
Liver Resection Improves Survival in Colorectal Cancer Patients: Causal-effects From Population-level Instrumental Variable Analysis.肝切除术改善结直肠癌患者的生存:基于人群水平工具变量分析的因果效应。
Ann Surg. 2019 Oct;270(4):692-700. doi: 10.1097/SLA.0000000000003485.
9
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.不可切除的单纯肝转移结直肠癌患者行肝移植术后的生存情况。
Ann Surg. 2020 Feb;271(2):212-218. doi: 10.1097/SLA.0000000000003404.
10
Historical perspective: Two decades of progress in treating metastatic colorectal cancer.历史视角:转移性结直肠癌治疗二十年的进展
J Surg Oncol. 2019 Apr;119(5):549-563. doi: 10.1002/jso.25431. Epub 2019 Feb 26.